2026 David P. Fairlie: Biology and Biochemistry Researcher – H-Index, Publications & Awards

Discipline name	D-Index	World Ranking	Current World Ranking	National Ranking	Current National Ranking	Publications	Citations
Biology and Biochemistry	108	1042	927	28	27	617	44084

Research.com Recognitions

2023 - Research.com Biology and Biochemistry in Australia Leader Award

Overview

David P. Fairlie is affiliated with the University of Queensland in Australia and has contributed extensively to research in immunology, molecular biology, and medicine. Their published work spans several interdisciplinary fields, with a strong focus on immune cell function and interaction as well as molecular pathways involved in immune responses.

Their main fields of study include:

Immunology and Microbiology
Biochemistry, Genetics and Molecular Biology
Medicine

Within these fields, Fairlie's subfields of study involve:

Immunology
Molecular Biology
Epidemiology
Cell Biology
Hematology

Key topics in their research encompass:

Immune Cell Function and Interaction
T-cell and B-cell Immunology
Chemical Synthesis and Analysis
Histone Deacetylase Inhibitors Research
Cytomegalovirus and herpesvirus research
Phagocytosis and Immune Regulation
Immunotherapy and Immune Responses

David P. Fairlie has co-authored publications with several frequent collaborators, including:

Jeffrey Y. W. Mak
James McCluskey
Ligong Liu
Jamie Rossjohn
Junxian Lim

Their work has been published in several prominent venues, with multiple publications in:

bioRxiv (Cold Spring Harbor Laboratory)
IUPHAR/BPS Guide to Pharmacology CITE
Proceedings of the National Academy of Sciences
Journal of Medicinal Chemistry
Journal of Biological Chemistry

Recent notable papers by David P. Fairlie include:

"Taking the Myc out of cancer: toward therapeutic strategies to directly inhibit c-Myc," published in 2021 in Molecular Cancer
"Systemic delivery of peptides by the oral route: Formulation and medicinal chemistry approaches," published in 2020 in Advanced Drug Delivery Reviews
"MAIT cells regulate NK cell-mediated tumor immunity," published in 2021 in Nature Communications
"Class IIa Histone Deacetylases Drive Toll-like Receptor-Inducible Glycolysis and Macrophage Inflammatory Responses via Pyruvate Kinase M2," published in 2020 in Cell Reports
"Absence of mucosal-associated invariant T cells in a person with a homozygous point mutation in MR1," published in 2020 in Science Immunology

Best Publications

The Future of Peptide‐based Drugs

David J. Craik;David P. Fairlie;Spiros Liras;David Price

2230
Citations
MR1 presents microbial vitamin B metabolites to MAIT cells

Lars Kjer-Nielsen;Onisha G Patel;Alexandra J Corbett;Jerome Le Nours;Jerome Le Nours

1400
Citations
Protease inhibitors: current status and future prospects.

Donmienne Leung;Giovanni Abbenante;David P. Fairlie

1230
Citations
Cu(II) Potentiation of Alzheimer Aβ Neurotoxicity CORRELATION WITH CELL-FREE HYDROGEN PEROXIDE PRODUCTION AND METAL REDUCTION

Xudong Huang;Math P. Cuajungco;Craig S. Atwood;Mariana A. Hartshorn

1021
Citations
T-cell activation by transitory neo-antigens derived from distinct microbial pathways

Alexandra Corbett;Sidonia B G Eckle;Richard William Birkinshaw;Ligong Liu

885
Citations
Characterization of copper interactions with alzheimer amyloid beta peptides: identification of an attomolar-affinity copper binding site on amyloid beta1-42.

Craig S. Atwood;Richard C. Scarpa;Xudong Huang;Robert D. Moir

811
Citations
Solution structure of amyloid beta-peptide(1-40) in a water-micelle environment. Is the membrane-spanning domain where we think it is?

Murray Coles;Wendy Bicknell;Andrew A. Watson;David P. Fairlie

661
Citations
Aqueous Dissolution of Alzheimer's Disease Aβ Amyloid Deposits by Biometal Depletion *

Robert A. Cherny;Robert A. Cherny;Jacinta T. Legg;Jacinta T. Legg;Catriona A. McLean;Catriona A. McLean;David P. Fairlie

659
Citations
Antigen-loaded MR1 tetramers define T cell receptor heterogeneity in mucosal-associated invariant T cells

Rangsima Reantragoon;Alexandra Corbett;Isaac G Sakala;Nicholas A Gherardin;Nicholas A Gherardin

625
Citations
Histone deacetylases as regulators of inflammation and immunity.

Melanie R. Shakespear;Maria A. Halili;Katharine M. Irvine;David P. Fairlie

606
Citations
Function, structure and therapeutic potential of complement C5a receptors

Monk Pn;Scola Am;Madala P;Fairlie Dp

470
Citations
Proteases universally recognize beta strands in their active sites.

Joel D. A. Tyndall;Tessa Nall;David P. Fairlie

469
Citations
Structure, function and pathophysiology of protease activated receptors.

Mark N. Adams;Rithwik Ramachandran;Mei Kwan Yau;Jacky Y. Suen

438
Citations
Activity of Recombinant Dengue 2 Virus NS3 Protease in the Presence of a Truncated NS2B Co-factor, Small Peptide Substrates, and Inhibitors

Donmienne Leung;Kate Schroder;Helen White;Ning-Xia Fang

408
Citations
Constraining Cyclic Peptides To Mimic Protein Structure Motifs

Timothy A. Hill;Nicholas E. Shepherd;Frederik Diness;David P. Fairlie

398
Citations
Protease inhibitors in the clinic.

Giovanni Abbenante;David P Fairlie

397
Citations
Alpha-synuclein structure and Parkinson’s disease – lessons and emerging principles

Richard M. Meade;David P. Fairlie;Jody M. Mason;Jody M. Mason

372
Citations
Orally Absorbed Cyclic Peptides

Daniel S. Nielsen;Nicholas E. Shepherd;Weijun Xu;Andrew J. Lucke

369
Citations
Single turn peptide alpha helices with exceptional stability in water.

Nicholas E Shepherd;Huy N Hoang;Giovanni Abbenante;David P Fairlie

351
Citations
Inflammatory lipid mediators in adipocyte function and obesity

Abishek Iyer;David P. Fairlie;Johannes B. Prins;Bruce D. Hammock

349
Citations